Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 17.42
(6.48%)
CNY 17.42
(6.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 194.63 Million | 149.81 Million | 96.19 Million | 121.82 Million | 64.07 Million | 89.11 Million |
| Net Income | 192.99 Million | 150.8 Million | 104.47 Million | 95.55 Million | 82.78 Million | 65.3 Million |
| Depreciation & Amortization | 46.32 Million | 47.49 Million | 47.16 Million | 42.94 Million | 32.22 Million | 27.72 Million |
| Deferred income taxes | 284.79 Thousand | -7098.70 | -200.4 Thousand | 252.1 Thousand | 1.93 Million | -70.6 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -47.53 Million | -48.76 Million | -56.11 Million | -21.97 Million | -57.26 Million | -9.56 Million |
| Other non-cash items | 3.39 Million | 286.61 Thousand | 665.07 Thousand | 5.29 Million | 6.33 Million | 5.65 Million |
| Investing Cash Flow | -223.72 Million | -246.89 Million | -297.68 Million | -38.24 Million | -73.89 Million | -81.25 Million |
| Investments in PPE | -311.97 Million | -175.59 Million | -55.81 Million | -58.65 Million | -56.48 Million | -88.1 Million |
| Acquisitions | 85 Thousand | 1.36 Million | 19 Thousand | 52 Thousand | 0.23 | - |
| Investment purchases | -630 Million | -812 Million | -345 Million | -52 Thousand | -6.74 Million | - |
| Sales/Maturities of investments | 718.17 Million | 739.23 Million | 103.33 Million | 2.64 Million | 2.53 Million | 2.81 Million |
| Other Investing Activities | 88.25 Million | 95.5 Thousand | -231.49 Thousand | 17.76 Million | -13.19 Million | 4.03 Million |
| Financing Cash Flow | -34.11 Million | -13.07 Million | 362.35 Million | -9 Million | -9.81 Million | -87.04 Million |
| Debt repayment | -1.77 Million | -1 Million | -59 Million | -53.9 Million | -55.9 Million | -202 Million |
| Dividends payments | -30.17 Million | -10.77 Million | -1.33 Million | -4.21 Million | -2.37 Million | -4.49 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.77 Million | -1.22 Million | 422.69 Million | 49.11 Million | 48.45 Million | 119.45 Million |
| Accounts receivables | -60.72 Million | -11.54 Million | -16.93 Million | -24.46 Million | -43.65 Million | -10.92 Million |
| Accounts payables | -2.65 Million | 8.41 Million | -7.43 Million | 17.44 Million | -734.4 Thousand | 5.4 Million |
| Inventory | 15.56 Million | -45.63 Million | -31.54 Million | -15.2 Million | -14.81 Million | -3.97 Million |
| Other working capital | -2.37 Million | -7098.67 | -200.4 Thousand | 252.09 Thousand | 1.93 Million | -5.59 Million |
| Cash at beginning of period | 180.89 Million | 291.04 Million | 130.19 Million | 55.64 Million | 75.26 Million | 154.41 Million |
| Cash at end of period | 117.69 Million | 180.89 Million | 291.04 Million | 130.19 Million | 55.64 Million | 75.26 Million |
| Capital Expenditure | -311.97 Million | -175.59 Million | -55.81 Million | -58.65 Million | -56.48 Million | -88.1 Million |
| Effect of forex changes on cash | 2398.30 | 11.34 Thousand | -13.34 Thousand | -18.8 Thousand | 5788.69 | 30.84 Thousand |
| Net cash flow / Change in cash | -63.2 Million | -110.14 Million | 160.84 Million | 74.55 Million | -19.62 Million | -79.15 Million |
| Free Cash Flow | -117.34 Million | -25.78 Million | 40.37 Million | 63.16 Million | 7.59 Million | 1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 66.01 Million | 53.54 Million | 51.64 Million | 192.99 Million | 50.23 Million | 46.65 Million |
| Depreciation & Amortization | 12.74 Million | 12.74 Million | 46.32 Million | 46.32 Million | -22.15 Million | 11.07 Million |
| Deferred income taxes | - | - | - | 284.79 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -93.13 Million | - | -45.15 Million | -47.53 Million | -775.91 Thousand | 775.91 Thousand |
| Other non-cash items | 20.93 Million | -24.8 Million | -51.64 Million | 3.39 Million | 13.5 Million | 24.44 Million |
| Investing Cash Flow | -28.92 Million | -53.83 Million | -106.76 Million | -223.72 Million | -8.5 Million | -150.2 Million |
| Investments in PPE | -18.92 Million | -66.01 Million | -70.76 Million | -311.97 Million | -79.27 Million | -107.66 Million |
| Acquisitions | - | - | - | 85 Thousand | 0.56 | 85 Thousand |
| Investment purchases | -460 Million | -140 Million | -190 Million | -630 Million | -20 Million | -360 Million |
| Sales/Maturities of investments | 450 Million | 152.18 Million | 153.99 Million | 718.17 Million | 90.77 Million | 317.37 Million |
| Other Investing Activities | -6.9 Million | 12.18 Million | -36 Million | 88.25 Million | - | 0.74 |
| Financing Cash Flow | -48.38 Million | 59.29 Million | -51.4 Million | -34.11 Million | -894.08 Thousand | -31.12 Million |
| Debt repayment | -10 Million | -60 Million | -50 Million | -1.77 Million | -50 Million | -50 Million |
| Dividends payments | -57.31 Million | -606.34 Thousand | -548.79 Thousand | -30.17 Million | -555.83 Thousand | -30.75 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -57.82 Million | -100 Thousand | -852.03 Thousand | -1.77 Million | 49.66 Million | 49.62 Million |
| Accounts receivables | -87.36 Million | - | -60.72 Million | -60.72 Million | 28.33 Million | -28.33 Million |
| Accounts payables | - | - | - | -2.65 Million | - | - |
| Inventory | -5.76 Million | - | 15.56 Million | 15.56 Million | -29.11 Million | 29.11 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 251.23 Million | 117.69 Million | 225.14 Million | 180.89 Million | 193.73 Million | 294.49 Million |
| Cash at end of period | 206.79 Million | 151.89 Million | 117.69 Million | 117.69 Million | 225.14 Million | 193.73 Million |
| Capital Expenditure | -18.92 Million | -66.01 Million | -70.76 Million | -311.97 Million | -79.27 Million | -107.66 Million |
| Effect of forex changes on cash | 14.32 Thousand | - | -10.94 Thousand | 2398.30 | 835.10 | 12.51 Thousand |
| Net cash flow / Change in cash | -44.44 Million | 34.19 Million | -107.45 Million | -63.2 Million | 31.41 Million | -100.75 Million |
| Free Cash Flow | 55.28 Million | -37.28 Million | -20.04 Million | -117.34 Million | -38.46 Million | -24.72 Million |
CIE
603393
MEGACPO
600648
ALESA
VTSYF